Plasticity and regulation of human bone marrow stromal osteoprogenitor cells: Potential implication in the treatment of age-related bone loss

Histology and Histopathology

Volumn 19, Issue 1, 2004, Pages 151-158

  Ahdjoudj, S ^a   Fromigue O ^a   Marie, Pierre J ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Adipocytes; Aging; Bone marrow; Human; Osteoblasts; Plasticity

Indexed keywords

ASCORBIC ACID; BONE MORPHOGENETIC PROTEIN 2; CALCITRIOL; CYTOKINE; DEXAMETHASONE; ESTROGEN; FIBROBLAST GROWTH FACTOR; GLUCOCORTICOID; GROWTH HORMONE; HORMONE; PARATHYROID HORMONE; PHOSPHATE; RETINOIC ACID; SOMATOMEDIN C; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ADIPOCYTE; AGING; BONE DEVELOPMENT; BONE DISEASE; BONE MARROW; CARTILAGE CELL; CELL DIFFERENTIATION; CELL LINE; CELL LINEAGE; DRUG INHIBITION; EVIDENCE BASED MEDICINE; GENE EXPRESSION; HORMONE ACTION; HUMAN; IN VIVO STUDY; MESENCHYME CELL; MOLECULAR MECHANICS; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOLYSIS; PLASTICITY; PROTEIN EXPRESSION; REVIEW; STEM CELL; STROMA CELL;

ADIPOCYTES; AGING; ANIMALS; BONE DISEASES, METABOLIC; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL LINE; CELL LINEAGE; CHONDROCYTES; GENE EXPRESSION REGULATION; HUMANS; MODELS, BIOLOGICAL; OSTEOBLASTS; STROMAL CELLS; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 1642515031     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (84)

1. Adams M., Reginato M.J., Shao D., Lazar M.A. and Chatterjee V.K. (1997). Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site. J. Biol. Chem. 272, 5128-5132.
2. Ahdjoudj S., Lasmoles F., Oyajobi B.O., Lomri A., Delannoy P. and Marie P.J. (2001). Reciprocal control of osteoblast/chondroblast and osteoblast/adipocyte differentiation of multipotential clonal human marrow stromal F/STRO-1(+) cells. J. Cell. Biochem. 81, 23-38.
3. Ahdjoudj S., Lasmoles F., Holy X., Zerath E. and Marie P.J. (2002). Transforming growth factor beta2 inhibits adipocyte differentiation induced by skeletal unloading in rat bone marrow stroma. J Bone Miner. Res. 17, 668-677.
4. Akune T.J, Kubota N., Harada Y., Azuma Y., Kadowski T., Nakamura K. and Kawaguchi H. (2001). Heterozygous PPARγ-deficient mice exhibit high bone mass with increased osteoblastic differentiation from bone marrow progenitors. J. Bone Miner. Res. 16, 1003.
5. Ashton B.A., Abdullah F., Cave J., Williamson M., Sykes B.C., Couch M. and Poser J.W. (1985). Characterization of cells with high alkaline phosphatase activity derived from human bone and marrow: Preliminary assessment of their osteogenicity. Bone 6, 313-319.
6. Bennett J.H., Joyner C.J., Triffitt J.T. and Owen M.E. (1991). Adipocytic cells cultured from marrow have osteogenic potential. J. Cell Sci. 99, 131-139.
7. Beresford J.N., Bennett J.H., Devlin C., Leboy P.S. and Owen M.E. (1992). Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures. J. Cell Sci. 102, 341-351.
8. Bianco P. and Robey P.G. (2000). Marrow stromal stem cells. J. Clin. Invest. 105, 1663-1668.
9. Burkhardt R., Kettner G., Bohm W., Schmidmeier M., Schlag R., Frisch B., Mallmann B., Eisenmenger W. and Gilg T. (1987). Changes in trabecular bone, hematopoiesis and bone marrow vessels in aplastic anemia, primary osteoporosis, and old age: A comparative histomorphometric study. Bone 8, 157-164.
10. Chan G.K., Deckelbaum R.A., Bolivar I., Goltzman D., Karaplis A.C. (2001). PTHrP inhibits adipocyte differentiation by down-regulating PPAR gamma activity via a MAPK-dependent pathway. Endocrinology 142, 4900-4909.
11. Charbord P., Tavian M., Humeau L. and Peault B. (1996). Early ontogeny of the human marrow from long bones: An immunohistochemical study of hematopoiesis and its microenvironment. Blood 87, 4109-4119.
12. Chin B.Y., Petrache I., Choi A.M. and Choi M.E. (1999). Transforming growth factor beta1 rescues serum deprivation-induced apoptosis via the mitogen-activated protein kinase (MAPK) pathway in macrophages. J. Biol. Chem. 274, 11362-11368.
13. Colter D.C., Sekiya I. and Prockop D.J. (2001). Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proc. Natl. Acad. Sci. USA 98, 7841-7845.
14. Dang Z.C., Van Bezooijen R.L., Karperien M., Papapoulos S.E. and Lowik C.W. (2002). Exposure of KS483 cells to estrogen enhances osteogenesis and inhibits adipogenesis. J Bone Miner. Res. 17, 394-405.
15. Dennis J.E., Merriam A., Awadallah A., Yoo J.U., Johnstone B. and Caplan A.I. (1999). A quadripotential mesenchymal progenitor cell isolated from the marrow of an adult mouse. J. Bone Miner. Res. 14, 700-709.
16. Diascro D.D. Jr., Vogel R.L., Johnson T.E., Witherup K.M., Pitzenberger S.M., Rutledge S.J., Prescott D.J., Rodan G.A. and Schmidt A. (1998). High fatty acid content in rabbit serum is responsible for the differentiation of osteoblasts into adipocyte-like cells. J. Bone Miner. Res. 13, 96-106.
17. D'Ippolito G., Schiller P.C., Ricordi C., Roos B.A. and Howard G.A. (1999). Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow. J. Bone Miner. Res. 14, 1115-11222.
18. Ducy P., Zhang R., Geoffroy V., Ridall A.L. and Karsenty G. (1997). Osf2/Cbfa1: A transcriptional activator of osteoblast differntiation. Cell 89, 747-754.
19. Ducy P., Starbuck M., Priemel M., Shen J., Pinero G., Geoffroy V., Amling M. and Karsenty G. (1999). A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev. 13, 1025-1036.
20. Eisman J.A. (1999). Genetics of osteoporosis. Endocr. Rev. 20, 788-804.
21. Friedenstein A.J., Chailakhyan R.K. and Gerasimov U.V. (1987). Bone marrow osteogenic stem cells: In vitro cultivation and transplantation in diffusion chambers. Cell Tissue Kinet. 20, 263-272.
22. Friedenstein A.J. (1976). Precursor cells of mechanocytes. Int. Rev. Cytol. 47, 327-359.
23. Fromigué O., Marie P.J. and Lomri A. (1997). Differential induction of the osteoblast phenotype by 1,25-dihydroxyvitamin D, dexamethasone and TGF-β2 in long-term cultures of human bone marrow stroma-derived osteoprogenitor cells. Cytokine 9, 613-623.
24. Fromigué O., Marie P.J. and Lomri A. (1998). Bone morphogenetic protein-2 and transforming growth factor-β2 interact to modulate human bone marrow stroma cell proliferation and differentiation. J. Cell. Biochem. 68, 411-426.
25. Fromigué O., Kheddoumi N., Lomri A., Marie P.J. and Body J.J. (2001). Breast cancer cells release factors that induced apoptosis in human bone marrow stromal cells. J. Bone Miner Res. 16, 1600-16010.
26. Gevers E.F., Loveridge N. and Robinson I.C. (2002). Bone marrow adipocytes: A neglected target tissue for growth hormone. Endocrinology 143, 4065-4073.
27. Gimble J.M., Morgan C., Kelly K., Wu X., Dandapani V., Wang C.S. and Rosen V. (1995). Bone morphogenetic proteins inhibit adipocyte differentiation by bone marrow stromal cells. J. Cell. Biochem. 58, 393-402.
28. Gimble J.M., Robinson C.E., Wu X. and Kelly K.A. (1996). The function of adipocytes in the bone marrow stroma: An update. Bone 19, 421-428.
29. Gori F., Thomas T., Hicok K.C., Spelsberg T.C. and Riggs B.L. (1999). Differentiation of human marrow stromal precursor cells: Bone morphogenetic protein-2 increases OSF2/CBFA1, enhances osteoblast commitment, and inhibits late adipocyte maturation. J. Bone Miner. Res. 14, 1522-1535.
30. Gronthos S. and Simmons P.J. (1995). The growth factor requirements of STRO-1-positive human bone marrow stromal precursors under serum-deprived conditions in vitro. Blood 85, 929-940.
31. Gurnell M., Wentworth J.M., Agostini M., Adams M., Collingwood T.N., Provenzano C., Browne P.O., Rajanayagam O., Burris T.P., Schwabe J.W., Lazar M.A. and Chatterjee V.K. (2000). A dominant-negative peroxisome proliferator-activated receptor gamma (PPARgamma) mutant is a constitutive represor and inhibits PPARgamma-mediated adipogenesis. J. Biol. Chem. 275, 5754-5759.
32. Hauner H. and Hochberg Z. (2002). Endocrinology of adipose tissue. Horm. Metab. Res. 34, 605-606.
33. Haynesworth S.E., Goshima J., Goldberg V.M. and Caplan A.I. (1992). Characterization of cells with osteogenic potential from human marrow. Bone 13, 81-88.
34. Hicok K.C., Thomas T., Gori F., Rickard D.J., Spelsberg T.C. and Riggs B.L. (1998). Development and characterization of conditionally immortalized osteoblast precursor cell lines from human bone marrow stroma. J. Bone Miner. Res. 13, 205-217.
35. Houghton A., Oyajobi B.O., Foster G.A., Russell R.G. and Stringer B.M. (1998). Immortalization of human marrow stromal cells by retroviral transduction with a temperature sensitive oncogene: Identification of bipotential precursor cells capable of directed differentiation to either an osteoblast or adipocyte phenotype. Bone 22, 7-16.
36. Hu E., Tontonoz P. and Spiegelman B.M. (1995). Transdifferentiation of myoblasts by the adipogenic transcription factors PPAR gamma and C/EBP alpha. Proc. Natl. Acad. Sci. USA 92, 9856-9860.
37. Jiang Y., Jahagirdar B.N., Reinhardt R.L., Schwartz R.E., Keene C.D., Ortiz-Gonzalez X.R., Reyes M., Lenvik T., Lund T., Blackstad M., Du J., Aldrich S., Lisberg A., Low W.C., Largaespada D.A. and Verfaillie C.M. (2002). Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418, 41-49.
38. Jilka R.L., Weinstein R.S., Takahashi K., Parfitt A.M. and Manolagas S.C. (1996). Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence. J. Clin. Invest. 97, 1732-1740.
39. Justesen J., Stenderup K., Eriksen E.F. and Kassem M. (2002). Maintenance of osteoblastic and adipocytic differentiation potential with age and osteoporosis in human marrow stromal cells cultures. Calcif. Tissue Int. 71, 36-44
40. Kassem M., Mosekilde L. and Eriksen E.F. (1994). Growth hormone stimulates proliferation of normal human bone marrow stromal osteoblast precursor cells in vitro. Growth Regul. 4, 131-135.
41. Kirkland J.L., Tchkonia T., Pirtskhalava T., Han J. and Karagiannides I. (2002). Adipogenesis and aging: Does aging make fat go MAD? Exp. Gerontol. 37, 757-767.
42. Kubota N., Terauchi Y., Yamauchi T., Kubota T., Moroi M., Matsui J., Eto K., Yamashita T., Kamon J., Satoh H., Yano W., Froguel P., Nagai R., Kimura S., Kadowaki T. and Noda T. (2002). Disruption of adiponectin causes insulin resistance and neointimal formation. J. Biol. Chem. 19, 25863-25866.
43. Kuznetsov S.A., Krebsbach P.H., Satomura K., Kerr J., Riminucci M., Benayahu D. and Robey P.G. (1997). Single-colony derived strains of human marrow stromal fibroblasts form boneafter transplantation in vivo. J. Bone Miner. Res 12, 1335-1347.
44. Lecka-Czernik B., Gubrij I., Moerman E.J., Kajkenova O., Lipschitz D.A., Manolagas S.C. and Jilka R.L. (1999). Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPARgamma2. J. Cell Biochem. 74, 357-371.
45. Machwate M., Zerath E., Holy X., Hott M., Modrowski D., Malouvier A. and Marie P.J. (1993). Skeletal unloading in rat decreases proliferation of rat bone and marrow-derived osteoblastic cells. Am. J. Physiol. 26, E790-E799.
46. Machwate M., Zerath E., Holy E., Hott M., Godet D., Lomri A. and Marie P.J. (1995). Systemic administration of transforming growth factor-beta 2 prevents the impaired bone formation and osteopenia by unloading in rats. J. Clin. Invest. 96, 1245-1259.
47. Manolagas S.C. (2000). Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr. Rev. 21, 115-137.
48. Marie P.J. (2001). The molecular genetics of bone formation: Implications for therapeutic interventions in bone disorders. Am. J. Pharmacogenomics 11, 75-87.
49. Martin R.B. and Zissimos S.L. (1991). Relationships between marrow fat and bone turnover in ovariectomized and intact rats. Bone 12, 123-131.
50. Meunier P., Aaron J. and Edouard C. and Vignon G. (1971). Osteoporosis and the replacement of cell populations of the marrow by adipose tissue. A quantitative study of 84 iliac bone biopsies. Clin. Orthop. 80, 147-154.
51. Muraglia A., Cancedda R. and Quarto R. (2000). Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J. Cell Sci. 113, 1161-1166.
52. Negishi Y., Kudo A. and Obinata A. (2000). Multipotency of a bone marrow stromal cell line, TBR31-2, established from ts-SV40 T antigen gene transgenic mice. Biochem. Biophys. Res. Commun. 268, 450-455.
53. Nishida S., Endo N., Yamagiwa H., Tanizawa T. and Takahashi H.E. (1999). Number of osteoprogenitor cells in human bone marrow markedly decreases after skeletal maturation. J. Bone Miner. Metab. 17, 171-177.
54. Nuttall M.E., Patton A.J., Olivera D.L., Nadeau D.P. and Gowen M. (1998). Human trabecular bone cells are able to express both osteoblastic and adipocytic phenotype: Implications for osteopenic disorders. J. Bone Miner. Res. 13, 371-382.
55. Oberfield J.L., Collins J.L., Holmes C.P., Goreham D.M., Cooper J.P., Cobb J.E., Lenhard J.M., Hull-Ryde E.A., Mohr C.P., Blanchard S.G., Parks D.J., Moore L.B., Lehmann J.M., Plunket K., Miller A.B., Milburn M.V., Kliewer S.A. and Willson T.M. (1999). A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiation. Proc. Natl. Acad. Sci. USA 96, 6102-6106.
56. Okazaki R., Inoue D., Shibata M., Saika M., Kido S., Ooka H., Tomiyama H., Sakamoto Y. and Matsumoto T. (2002). Estrogen promotes early osteoblast differentiation and inhibits adipocyte differentiation in mouse bone marrow stromal cell lines that express estrogen receptor (ER) alpha or beta. Endocrinology 143, 2349-2356.
57. Oyajobi B.O, Lomri A., Hott M. and Marie P.J. (1999). Isolation and characterization of human clonogenic osteoblast progenitors immunoselected from fetal bone marrow using STRO-1 monoclonal antibody. J. Bone Miner. Res. 14, 351-361.
58. Owen M. (1988). Marrow stromal stem cells. J. Cell Sci. (Suppl 10), 63-76.
59. Park S.R., Oreffo R.O. and Triffitt J.T. (1999). Interconversion potential of cloned human marrow adipocytes in vitro. Bone 24, 549-554.
60. Parhami F., Jackson S.M., Tintut Y., Balucan J.P., Territo M. and Demer L.L. (1999). Atherogenic diet and minimally oxidized low density lipoprotein inhibit osteogenic and promote adipogenic differentiation of marrow stromal cells. J. Bone Miner. Res. 14, 2067-2078.
61. Pereira R.F., Halford K.W. and O'Hara M.D. (1995). Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc. Natl. Acad. Sci. USA 92, 4857-4861.
62. Pittenger M.F, Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S. and Marshak D.R. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284, 143-147.
63. Prockop D.J. (1997). Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276, 71-74.
64. Qi H., Aguiar D.J., Williams S.M., La Pean A., Pan W. and Verfaillie C.M. (2003). Identification of genes responsible for osteoblast differentiation from human mesodermal progenitor cells. Proc. Natl. Acad. Sci. USA 100, 3305-3310.
65. Rickard D.J., Kassem M., Hefferan T.E., Sarkar G., Spelsberg T.C. and Riggs B.L. (1996). Isolation and characterization of osteoblast precursor cells from human bone marrow. J. Bone Miner. Res. 11, 312-324.
66. Riggs B.L., Khosla S. and Melton L.J. 3rd (2002). Sex steroids and the construction and conservation of the adult skeleton. Endocr. Rev. 23, 279-302.
67. Rosen E.D. and Spiegelman B.M. (2000). Molecular regulation of adipogenesis. Annu. Rev. Cell. Dev. Biol. 16, 145-171.
68. Rosen E.D., Sarraf P., Troy A.E., Bradwin G., Moore K., Milstone D.S., Spiegelman B.M. and Mortensen R.M. (1999). PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol. Cell 4, 611-617.
69. Rozman C., Feliu E., Berga L., Reverter J.C., Climent C. and Ferran M.J. (1989). Age-related variations of fat tissue fraction in normal human bone marrow depend both on size and number of adipocytes: A stereological study. Exp. Hematol. 17, 34-37.
70. Sekiya I., Vuoristo J.T. and Larson B.L. and Prockop D.J. (2002). In vitro cartilage formation by human adult stem cells from bone marrow stroma defines the sequence of cellular and molecular events during chondrogenesis. Proc. Natl. Acad. Sci. USA 99, 4397-4402.
71. Shui C., Spelsberg T.C., Riggs B.L. and Khosla S. (2003). Changes in Runx2/Cbfa1 expression and activity during osteoblastic differentiation of human bone marrow stromal cells. J. Bone Miner. Res. 18, 213-221.
72. Skillington J., Choy L. and Derynck R. (2002). Bone morphogenetic protein and retinoic acid signaling cooperate to induce osteoblast differentiation of preadipocytes. J. Cell Biol. 14, 135-146
73. Spinella-Jaegle S., Rawadi G., Kawai S., Gallea S., Faucheu C., Mollat P., Courois B., Bergaud B., Ramez V., Blanchet A.M., Adelmant G., Baron R. and Roman-Roman S. (2001). Sonic hedgehog increases the commitment of pluripotent mesenchymal cells into the osteoblastic lineage and abolishes adipocytic differentiation. J. Cell Sci. 114, 2085-2094.
74. Stewart K., Walsh S., Screen J., Jefferiss C.M., Chainey J., Jordan G.R. and Beresford J.N. (1999). Further characterization of cells expressing STRO-1 in cultures of adult human bone marrow stromal cells. J. Bone Miner. Res. 14, 1345-1356.
75. Tintut Y., Parhami F., Karsenty G. and Demer L.L. (1999). Inhibition of osteoblast-specific transcription factor Cbfa1 by the cAMP pathway in osteoblastic cells. Ubiquitin/proteasome-dependent regulation. J. Biol. Chem. 274, 28875-28889.
76. Thomas T., Gori F., Spelsberg T.C., Khosla S., Riggs B.L. and Conover C.A. (1999a). Response of bipotential human marrow stromal cells to insulin-like growth factors: Effect on binding protein production, proliferation, and commitment to osteoblasts and adipocytes. Endocrinology 140, 5036-5044.
77. Thomas T., Gori F., Khosla S., Jensen M.D., Burguera B. and Riggs B.L. (1999b). Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology 140, 1630-1638
78. Thompson D.L., Lum K.D., Nygaard S.C., Kuestner R.E., Kelly K.A., Gimble J.M. and Moore E.E (1998). The derivation and characterization of stromal cell lines from the bone marrow of p53-/-mice: New insights into osteoblast and adipocyte differentiation. J. Bone Miner. Res. 13, 195-204.
79. Verma S., Rajaratnam J.H., Denton J., Hoyland J.A. and Byers R.J. (2002). Adipocytic proportion of bone marrow is inversely related to bone formation in osteoporosis. J. Clin. Pathol. 55, 693-698.
80. Walsh S., Jefferiss C., Stewart K., Jordan G.R., Screen J. and Beresford J.N. (2000). Expression of the developmental markers STRO-1 and alkaline phosphatase in cultures of human marrow stromal cells: Regulation by fibroblast growth factor (FGF)-2 and relationship to the expression of FGF receptors 1-4. Bone 27, 185-195.
81. Wright H.M., Clish C.B., Mikami T., Hauser S., Yanagi K., Hiramatsu R., Serhan C.N. and Spiegelman B.M. (2000). A synthetic antagonist for the peroxisome proliferator-activated receptor gamma inhibits adipocyte differentiation. J. Biol. Chem. 275, 1873-1877.
82. Xiao G., Cui Y., Ducy P., Karsenty G. and Franceschi R.T. (1997). Ascorbic acid-dependent activation of the osteocalcin promoter in MC3T3-E1 preosteoblasts: Requirement for collagen matrix synthesis and the presence of an intact OSE2 sequence. Mol. Endocrinol. 11, 1103-1113.
83. Yamaguchi A., Komori T. and Suda T. (2000). Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1. Endocr. Rev. 21, 393-411.
84. Zhang X., Sobue T. and Hurley M.M. (2002). FGF-2 increases colony formation, PTH receptor, and IGF-1 mRNA in mouse marrow stromal cells. Biochem. Biophys. Res. Commun. 290, 526-531.